Sun.Dec 12, 2021

article thumbnail

CAR-T therapy trials show promise for earlier use in lymphoma

Bio Pharma Dive

Study results presented at ASH suggest Gilead's Yescarta and Bristol Myers Squibb's Breyanzi could become replacements for stem cell transplants in treating the blood cancer.

Trials 339
article thumbnail

Why the Next Generation of Drugs Can’t Depend on Legacy Drug Packaging

Pharma Mirror

By Christopher Weikart, Chief Scientist at SiO2 Materials Science Why is an incredibly innovative and forward-thinking industry like pharmaceuticals being held back by the products that haven’t changed in over a century? The glass used to package, store, and deliver drugs today was created in 1881 — just 16 years after the Civil War ended — and has changed very little since then, and it’s these vials that drug companies, who are creating ever-evolving, more complex drugs, are beholde

Packaging 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

On the hunt for new ALS drugs, researchers see progress, and a long road ahead

Bio Pharma Dive

The fatal nerve disease has few treatments.

Genetics 258
article thumbnail

Life arose on hydrogen energy

Scienmag

December 13, 2021 – How did the first chemical reactions get started at the origin of life and what was their source of energy? Researchers at the Heinrich Heine University Düsseldorf (HHU) have reconstructed the metabolism of the last universal common ancestor, LUCA. They found that almost all chemical steps used by primordial life to […].

article thumbnail

Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

article thumbnail

Efficacy and Safety of COVID-19 Convalescent Plasma in Hospitalized Patients

JAMA Internal Medicine

This randomized clinical trial examines the use of convalescent plasma from patients with COVID-19 in hospitalized patients with COVID-19 who are not receiving invasive oxygenation treatment.

article thumbnail

The sky’s the limit: Using airborne DNA to monitor insect biodiversity

Scienmag

Scientists at Lund University have discovered for the first time that it is possible to detect insect DNA in the air. Using air from three sites in Sweden, insect DNA from 85 species could be identified. This offers scope for exploring a whole new way to monitor terrestrial biodiversity. Credit: Fabian Roger Scientists at Lund University have […].

DNA 91

More Trending

article thumbnail

Solar parks could boost bumble bee numbers in a win-win for nature

Scienmag

New research shows that simple changes to how UK solar parks are managed could boost ground nesting bumble bee populations in the parks and surrounding areas, providing an additional benefit on top of renewable energy. Credit: Hollie Blaydes. New research shows that simple changes to how UK solar parks are managed could boost ground nesting […].

article thumbnail

DNA DATA STORAGE: RESEARCH LANDSCAPE AND FUTURE PROSPECTS

Roots Analysis

DNA data storage involves encoding and decoding binary data to and from synthesized strands of DNA. It offers generous, long-lasting, and stable data storage solution with orders of magnitude relatively higher than current storage mediums. Owing to the numerous benefits offered by DNA data storage as compared to other mediums, it is anticipated that this technology in a short term, will exceed the performance and cost characteristics of other storage devices while retaining the advantages specif

DNA 52
article thumbnail

Indigenous communities hold a huge and unique source of ecological knowledge

Scienmag

A study has found that indigenous people in the rainforests of Gabon have knowledge of plant and fruit-eating animal interactions that exceeds that found in academic literature. Credit: Clémentine Durand-Bessart A study has found that indigenous people in the rainforests of Gabon have knowledge of plant and fruit-eating animal interactions that exceeds that found in […].

article thumbnail

Dental Crowns Takapuna Updated By Auckland Family Dental Milford

BioTech 365

Dental Crowns Takapuna Updated By Auckland Family Dental Milford Dental Crowns Takapuna Updated By Auckland Family Dental Milford Auckland Family Dental Milford (09-489 8354) updated its dental crowns treatments for patients in Milford, Takapuna, Glenfield and other North Shore Suburbs … Continue reading →

52
article thumbnail

The New Age of Decentralized Clinical Trials

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

article thumbnail

New study in primary liver cancer calls for novel strategies targeting a dynamic landscape of heterogeneous tumors

Scienmag

Singapore, 13 December 2021 – Clinician scientists and scientists from the National Cancer Centre Singapore (NCCS) and A*STAR’s Genome Institute of Singapore (GIS), in collaboration with Singapore General Hospital (SGH), the National University Health System, Duke-NUS Medical School, Nanyang Technological University, and collaborators from China, Malaysia, Thailand and the Philippines, have described a dynamic genomic […].

Genome 82
article thumbnail

GLIDE: Yemeni Doctor Wins Global Disease Elimination Award to Help Keep the Country Free of Lymphatic Filariasis

BioTech 365

GLIDE: Yemeni Doctor Wins Global Disease Elimination Award to Help Keep the Country Free of Lymphatic Filariasis GLIDE: Yemeni Doctor Wins Global Disease Elimination Award to Help Keep the Country Free of Lymphatic Filariasis Dr Abdul Samid Al-Kubati is one … Continue reading →

Doctors 52
article thumbnail

Trial identifies five-drug combo for ‘ultra high risk’ bone marrow cancer

Scienmag

A combination of five existing drugs keeps cancer at bay for longer in patients with a highly aggressive type of bone marrow cancer, a major new trial reveals. The five-drug cocktail, along with a stem cell transplant, allowed people with ultra-high risk multiple myeloma to live longer before their disease progressed than those who received […].

Trials 80
article thumbnail

Interim Data From Phase III HAVEN 6 Study Demonstrate Favorable Safety and Efficacy Profile of Genentech’s Hemlibra (emicizumab-kxwh) in People With Moderate or Mild Hemophilia A

BioTech 365

Interim Data From Phase III HAVEN 6 Study Demonstrate Favorable Safety and Efficacy Profile of Genentech’s Hemlibra (emicizumab-kxwh) in People With Moderate or Mild Hemophilia A Interim Data From Phase III HAVEN 6 Study Demonstrate Favorable Safety and Efficacy Profile … Continue reading →

52
article thumbnail

Roles and Responsibilities of Specialized Clinical Supply Experts

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

article thumbnail

Hospital health care workers in Quebec were at high risk of SARS-CoV-2 infection in first wave of the pandemic

Scienmag

Hospital health care workers in Quebec had high rates of antibodies (seroprevalence) against SARS-CoV-2 after the first wave of the COVID-19 pandemic, especially in hospitals with outbreaks, found a study published in CMAJ (Canadian Medical Association Journal) [link] In Quebec, 25% of all COVID-19 cases were among health care workers during the first phase of […].

article thumbnail

New Study Suggests That Masimo SedLine® Brain Function Monitoring May Aid Early Identification of Patients at Risk of Developing Postoperative Delirium

BioTech 365

New Study Suggests That Masimo SedLine® Brain Function Monitoring May Aid Early Identification of Patients at Risk of Developing Postoperative Delirium New Study Suggests That Masimo SedLine® Brain Function Monitoring May Aid Early Identification of Patients at Risk of Developing … Continue reading →

article thumbnail

Equitable COVID-19 pandemic recovery in Canada: New guideline

Scienmag

From income to housing to addressing racism and more, a new guideline proposes 13 ways to address inequities exposed and worsened by COVID-19 in the pandemic recovery period. The guidance is published in CMAJ (Canadian Medical Association Journal) [link] If not addressed, these inequities will continue to threaten the health of many Canadians. “Coordinated pandemic responses […].

61
article thumbnail

KOREA PACK & ICPI WEEK (Int’l Cosmetic and Pharmaceutical Industry Week) 2022 to Provide O2O Service Connecting Offline Exhibition to the Online Business Platform

BioTech 365

KOREA PACK & ICPI WEEK (Int’l Cosmetic and Pharmaceutical Industry Week) 2022 to Provide O2O Service Connecting Offline Exhibition to the Online Business Platform KOREA PACK & ICPI WEEK (Int’l Cosmetic and Pharmaceutical Industry Week) 2022 to Provide O2O Service … Continue reading →

article thumbnail

The New Age of Decentralized Clinical Trials

This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.

article thumbnail

Reminders of ongoing advances in science instil trust in changing COVID-19 guidance

Scienmag

Officials could boost public trust in COVID-19 health recommendations by including reminders that changes to recommendations are expected as science evolves, a new study has found. The research team first predicted and found that reminders of the frequent changes in safety guidelines caused people to judge experts negatively. “People have often suggested that the revisions […].

article thumbnail

Teladoc Health Is Providing Free Virtual Health Care Services to Those Impacted by Kentucky Tornadoes

BioTech 365

Teladoc Health Is Providing Free Virtual Health Care Services to Those Impacted by Kentucky Tornadoes Teladoc Health Is Providing Free Virtual Health Care Services to Those Impacted by Kentucky Tornadoes PURCHASE, NY, Dec.

40
article thumbnail

Which pharmaceutical companies have the most drug patents in Taiwan?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most patents in Taiwan. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…. The post Which pharmaceutical companies have the most drug patents in Taiwan? appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52
article thumbnail

Hebei Makes Contribution to Stable Supply of Global Anti-Epidemic Medical Supplies

BioTech 365

Hebei Makes Contribution to Stable Supply of Global Anti-Epidemic Medical Supplies Hebei Makes Contribution to Stable Supply of Global Anti-Epidemic Medical Supplies Beijing, China, Dec.

40
article thumbnail

Accelerating Clinical Supply Through Integrated Drug Development

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.

article thumbnail

Editas Medicine Reports Preclinical Data Demonstrating Robust Tumor Reduction and Clearance Using Novel, Engineered iNK Cells at the American Society of Hematology Annual Meeting

BioTech 365

Editas Medicine Reports Preclinical Data Demonstrating Robust Tumor Reduction and Clearance Using Novel, Engineered iNK Cells at the American Society of Hematology Annual Meeting Editas Medicine Reports Preclinical Data Demonstrating Robust Tumor Reduction and Clearance Using Novel, Engineered iNK Cells … Continue reading →

article thumbnail

Avenue Therapeutics Prices $2.0 Million Underwritten Public Offering of Common Stock

BioTech 365

Avenue Therapeutics Prices $2.0 Million Underwritten Public Offering of Common Stock Avenue Therapeutics Prices $2.0 Million Underwritten Public Offering of Common Stock NEW YORK, Dec. 12, 2021 (GLOBE NEWSWIRE) — Avenue Therapeutics, Inc.

40
article thumbnail

GLIDE: Vaccination Incentives and Next Generation Sequencing – Two Pakistani Doctors Employ Innovative Techniques to Eradicate Polio

BioTech 365

GLIDE: Vaccination Incentives and Next Generation Sequencing – Two Pakistani Doctors Employ Innovative Techniques to Eradicate Polio GLIDE: Vaccination Incentives and Next Generation Sequencing – Two Pakistani Doctors Employ Innovative Techniques to Eradicate Polio ?

Doctors 52
article thumbnail

NexImmune Announces Preliminary Phase 1/2 NEXI-002 Results in Patients with Multiple Myeloma

BioTech 365

NexImmune Announces Preliminary Phase 1/2 NEXI-002 Results in Patients with Multiple Myeloma NexImmune Announces Preliminary Phase 1/2 NEXI-002 Results in Patients with Multiple Myeloma Initial Phase 1/2 data presented at the 63rd American Society of Hematology (ASH) Annual Meeting and … Continue reading →

40
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Pfizer and Sangamo Announce Updated Phase 1/2 Results Showing Sustained Bleeding Control in Highest Dose Cohort Through Two Years Following Hemophilia A Gene Therapy

BioTech 365

Pfizer and Sangamo Announce Updated Phase 1/2 Results Showing Sustained Bleeding Control in Highest Dose Cohort Through Two Years Following Hemophilia A Gene Therapy Pfizer and Sangamo Announce Updated Phase 1/2 Results Showing Sustained Bleeding Control in Highest Dose Cohort … Continue reading →

article thumbnail

New Data from CARTITUDE-1 Study Show Continued Deep and Durable Responses of Ciltacabtagene Autoleucel (cilta-cel) in Treatment of Heavily Pre-treated Patients with Multiple Myeloma

BioTech 365

New Data from CARTITUDE-1 Study Show Continued Deep and Durable Responses of Ciltacabtagene Autoleucel (cilta-cel) in Treatment of Heavily Pre-treated Patients with Multiple Myeloma New Data from CARTITUDE-1 Study Show Continued Deep and Durable Responses of Ciltacabtagene Autoleucel (cilta-cel) in … Continue reading →

52
article thumbnail

New and Updated Data Demonstrating Sustained Treatment Response in Patients Treated in Largest Sickle Cell Gene Therapy Program To-Date Presented at ASH21 and Published in NEJM

BioTech 365

New and Updated Data Demonstrating Sustained Treatment Response in Patients Treated in Largest Sickle Cell Gene Therapy Program To-Date Presented at ASH21 and Published in NEJM New and Updated Data Demonstrating Sustained Treatment Response in Patients Treated in Largest Sickle … Continue reading →

article thumbnail

Seagen Announces Preliminary Results from Phase 2 Clinical Trial of ADCETRIS® (brentuximab vedotin) in Novel Combination of Agents for Patients with Advanced Stage Classical Hodgkin Lymphoma

BioTech 365

Seagen Announces Preliminary Results from Phase 2 Clinical Trial of ADCETRIS® (brentuximab vedotin) in Novel Combination of Agents for Patients with Advanced Stage Classical Hodgkin Lymphoma Seagen Announces Preliminary Results from Phase 2 Clinical Trial of ADCETRIS® (brentuximab vedotin) in … Continue reading →

article thumbnail

The New Clinical Trial Supply Chain: Resilient, Flexible, and Patient-Centric

The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.